HES1 and melanoma: We investigated the effect of PHB ligands on the main survival pathways in melanoma in three representative melanoma lines with different mutational status and observed that JI130 (Figure 4A,B) and MEL56 (Figure 4C,D) inhibit PHBs and the HES1 expression that express the latter.